{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:28:13Z","timestamp":1792304893596,"version":"4.4.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010296","name":"James B. Pendleton Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009658","name":"American Pain Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["R21 AI145372"],"award-info":[{"award-number":["R21 AI145372"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI036214"],"award-info":[{"award-number":["AI036214"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["U54 CA260543"],"award-info":[{"award-number":["U54 CA260543"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI157155"],"award-info":[{"award-number":["AI157155"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["5T32AI007384"],"award-info":[{"award-number":["5T32AI007384"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["12-2"],"award-info":[{"award-number":["12-2"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"International AIDS Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020189","name":"John and Mary Tu Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006206","name":"Biological and Environmental Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P41GM103393"],"award-info":[{"award-number":["P41GM103393"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CHAVD UM1 AI44462"],"award-info":[{"award-number":["CHAVD UM1 AI44462"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-004923"],"award-info":[{"award-number":["INV-004923"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011664","name":"SLAC National Accelerator Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006151","name":"Basic Energy Sciences","doi-asserted-by":"publisher","award":["DE-AC02\\u201376SF00515"],"award-info":[{"award-number":["DE-AC02\\u201376SF00515"]}],"id":[{"id":"10.13039\/100006151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.immuni.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T01:23:22Z","timestamp":1676510602000},"page":"669-686.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"title":["Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease"],"prefix":"10.1016","volume":"56","author":[{"given":"Panpan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-ting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Beutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longping V.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Anzanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Dueker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Musharrafieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazio","family":"Capozzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Limbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Parren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Rawlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davey M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nemazee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Safonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Briney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Gralinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiees","family":"Andrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2023.02.005_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Title: immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy trial","volume":"375","author":"Gilbert","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib5","doi-asserted-by":"crossref","first-page":"eabi9915","DOI":"10.1126\/scitranslmed.abi9915","article-title":"Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection","volume":"13","author":"Greaney","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","article-title":"Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies","volume":"182","author":"Barnes","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.02.005_bib7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1126\/science.abd2321","article-title":"Structural basis of a shared antibody response to SARS-CoV-2","volume":"369","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/imr.13084","article-title":"Protective neutralizing epitopes in SARS-CoV-2","volume":"310","author":"Liu","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2023.02.005_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","article-title":"Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.abh1139","article-title":"Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants","volume":"373","author":"Yuan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib16","doi-asserted-by":"crossref","first-page":"e1010260","DOI":"10.1371\/journal.ppat.1010260","article-title":"Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants","volume":"18","author":"Mittal","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2023.02.005_bib17","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in\u00a0vitro studies","author":"Cox","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.immuni.2023.02.005_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2021.2088","article-title":"SARS-CoV-2 viral variants-tackling a moving target","volume":"325","author":"Mascola","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.immuni.2023.02.005_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.immuni.2023.02.005_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift","volume":"602","author":"Cameroni","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization","volume":"602","author":"Cele","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","article-title":"Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron","volume":"602","author":"Carre\u00f1o","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.02.005_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chom.2022.11.012","article-title":"Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2","volume":"31","author":"Qu","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2023.02.005_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1473-3099(22)00733-2","article-title":"Omicron sublineage BQ.1.1 resistance to monoclonal antibodies","volume":"23","author":"Arora","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.immuni.2023.02.005_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41467-023-36561-6","article-title":"Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies","volume":"14","author":"Planas","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.02.005_bib32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2023.02.005_bib33","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1073\/pnas.1517719113","article-title":"SARS-like WIV1-CoV poised for human emergence","volume":"113","author":"Menachery","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2023.02.005_bib34","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/d41586-021-00340-4","article-title":"Variant-proof vaccines - invest now for the next pandemic","volume":"590","author":"Burton","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1126\/science.abh0447","article-title":"A universal coronavirus vaccine","volume":"371","author":"Koff","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMp2118468","article-title":"Universal coronavirus vaccines - an urgent need","volume":"386","author":"Morens","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-021-03817-4","article-title":"Broad sarbecovirus neutralization by a human monoclonal antibody","volume":"597","author":"Tortorici","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib41","doi-asserted-by":"crossref","first-page":"eabj7125","DOI":"10.1126\/scitranslmed.abj7125","article-title":"A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice","volume":"14","author":"Martinez","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib43","doi-asserted-by":"crossref","first-page":"eabl9605","DOI":"10.1126\/scitranslmed.abl9605","article-title":"Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques.","volume":"14","author":"He","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib44","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.cell.2021.06.021","article-title":"In\u00a0vitro and in\u00a0vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies","volume":"184","author":"Li","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.02.005_bib45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.abf4830","article-title":"Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody","volume":"371","author":"Rappazzo","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib46","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41590-022-01222-1","article-title":"Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses","volume":"23","author":"He","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2023.02.005_bib47","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s42003-022-03700-6","article-title":"Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron","volume":"5","author":"Liu","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.immuni.2023.02.005_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205784119","article-title":"A broad and potent neutralization epitope in SARS-related coronaviruses","volume":"119","author":"Yuan","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2023.02.005_bib49","doi-asserted-by":"crossref","first-page":"109760","DOI":"10.1016\/j.celrep.2021.109760","article-title":"Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies","volume":"36","author":"Jette","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2023.02.005_bib50","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2023.02.005_bib52","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1038\/s41467-021-23074-3","article-title":"Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection","volume":"12","author":"Song","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.02.005_bib53","doi-asserted-by":"crossref","first-page":"eabi9215","DOI":"10.1126\/scitranslmed.abi9215","article-title":"A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection","volume":"14","author":"Zhou","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib54","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.abj3321","article-title":"Broad Betacoronavirus neutralization by a stem helix-specific human antibody","volume":"373","author":"Pinto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib55","doi-asserted-by":"crossref","first-page":"109929","DOI":"10.1016\/j.celrep.2021.109929","article-title":"Stabilized coronavirus spike stem elicits a broadly protective antibody","volume":"37","author":"Hsieh","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2023.02.005_bib56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41594-021-00596-4","article-title":"Structural basis for broad coronavirus neutralization","volume":"28","author":"Sauer","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.immuni.2023.02.005_bib57","doi-asserted-by":"crossref","first-page":"110210","DOI":"10.1016\/j.celrep.2021.110210","article-title":"Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern","volume":"38","author":"Li","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2023.02.005_bib58","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41467-021-21968-w","article-title":"A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.02.005_bib59","doi-asserted-by":"crossref","first-page":"109353","DOI":"10.1016\/j.celrep.2021.109353","article-title":"Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects","volume":"36","author":"Jennewein","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2023.02.005_bib60","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s42003-022-03262-7","article-title":"Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit","volume":"5","author":"Hurlburt","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.immuni.2023.02.005_bib61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chom.2022.10.010","article-title":"Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses","volume":"31","author":"Dacon","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2023.02.005_bib62","doi-asserted-by":"crossref","first-page":"e1010691","DOI":"10.1371\/journal.ppat.1010691","article-title":"Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody","volume":"18","author":"Piepenbrink","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2023.02.005_bib63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.coi.2018.04.025","article-title":"Strategies for a multi-stage neutralizing antibody-based HIV vaccine","volume":"53","author":"Andrabi","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2023.02.005_bib64","doi-asserted-by":"crossref","first-page":"aax4380","DOI":"10.1126\/science.aax4380","article-title":"A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses","volume":"366","author":"Steichen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.immuni.2023.02.005_bib67","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.chom.2020.04.022","article-title":"Rational vaccine design in the time of COVID-19","volume":"27","author":"Burton","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2023.02.005_bib68","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/v13040628","article-title":"Neutralizing antibody therapeutics for COVID-19","volume":"13","author":"Hurt","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.immuni.2023.02.005_bib69","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.abj2258","article-title":"Hybrid immunity","volume":"372","author":"Crotty","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib70","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib71","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib72","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.immuni.2020.10.005","article-title":"Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses","volume":"53","author":"Guthmiller","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.02.005_bib73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-019-0879-y","article-title":"Commonality despite exceptional diversity in the baseline human antibody repertoire","volume":"566","author":"Briney","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib74","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41586-022-05371-z","article-title":"Functional antibodies exhibit light chain coherence","volume":"611","author":"Jaffe","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib75","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.immuni.2015.10.014","article-title":"Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design","volume":"43","author":"Andrabi","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.02.005_bib76","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.celrep.2019.04.082","article-title":"The chimpanzee SIV envelope trimer: structure and deployment as an HIV vaccine template","volume":"27","author":"Andrabi","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2023.02.005_bib77","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib78","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1038\/s41467-020-17371-6","article-title":"Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein","volume":"11","author":"Fan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.02.005_bib79","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib80","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","author":"Watanabe","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.02.005_bib81","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","article-title":"A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice","volume":"183","author":"Leist","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.02.005_bib82","doi-asserted-by":"crossref","first-page":"16226","DOI":"10.1038\/nmicrobiol.2016.226","article-title":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome","volume":"2","author":"Cockrell","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2023.02.005_bib83","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2017.12.006","article-title":"Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease","volume":"517","author":"Douglas","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2023.02.005_bib84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMe2034495","article-title":"Monoclonal antibodies to disrupt progression of early Covid-19 infection","volume":"384","author":"Cohen","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib85","doi-asserted-by":"crossref","first-page":"eabl7430","DOI":"10.1126\/scitranslmed.abl7430","article-title":"A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus","volume":"14","author":"Fischer","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib86","doi-asserted-by":"crossref","first-page":"e20201993","DOI":"10.1084\/jem.20201993","article-title":"Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in\u00a0vivo","volume":"218","author":"Sch\u00e4fer","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib87","doi-asserted-by":"crossref","first-page":"675679","DOI":"10.3389\/fimmu.2021.675679","article-title":"High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients","volume":"12","author":"Greenbaum","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2023.02.005_bib88","doi-asserted-by":"crossref","first-page":"eabj2901","DOI":"10.1126\/sciimmunol.abj2901","article-title":"Early cross-coronavirus reactive signatures of humoral immunity against COVID-19","volume":"6","author":"Kaplonek","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2023.02.005_bib89","doi-asserted-by":"crossref","first-page":"e0076022","DOI":"10.1128\/jvi.00760-22","article-title":"Persistent maintenance of intermediate memory B cells following SARS-CoV-2 infection and vaccination recall response","volume":"96","author":"Pu\u0161nik","year":"2022","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2023.02.005_bib90","doi-asserted-by":"crossref","first-page":"eabi6950","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2023.02.005_bib91","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1126\/science.abh1282","article-title":"Prior SARS-CoV-2 infection rescues B and T\u00a0cell responses to variants after first vaccine dose","volume":"372","author":"Reynolds","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.02.005_bib92","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12517","article-title":"The quest for an antibody-based HIV vaccine","volume":"275","author":"Haynes","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2023.02.005_bib93","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nri3516","article-title":"Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning","volume":"13","author":"Kwong","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2023.02.005_bib94","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-021-03594-0","article-title":"Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses","volume":"594","author":"Saunders","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.02.005_bib95","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.02.005_bib96","doi-asserted-by":"crossref","first-page":"eabi5735","DOI":"10.1126\/scitranslmed.abi5735","article-title":"A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates","volume":"14","author":"Joyce","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2023.02.005_bib97","doi-asserted-by":"crossref","first-page":"17880","DOI":"10.1073\/pnas.1004728107","article-title":"Elicitation of structure-specific antibodies by epitope scaffolds","volume":"107","author":"Ofek","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2023.02.005_bib98","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.str.2010.06.010","article-title":"Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope","volume":"18","author":"Correia","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.immuni.2023.02.005_bib99","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.immuni.2023.02.005_bib100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/JVI.01791-15","article-title":"New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency","volume":"90","author":"Doria-Rose","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2023.02.005_bib101","doi-asserted-by":"crossref","first-page":"109109","DOI":"10.1016\/j.celrep.2021.109109","article-title":"Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2","volume":"35","author":"Zhou","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2023.02.005_bib102","series-title":"Massively scalable genetic analysis of antibody repertoires","author":"Briney","year":"2018"},{"key":"10.1016\/j.immuni.2023.02.005_bib103","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/bioinformatics\/btz921","article-title":"Logomaker: beautiful sequence logos in Python","volume":"36","author":"Tareen","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2023.02.005_bib104","doi-asserted-by":"crossref","first-page":"e1007819","DOI":"10.1371\/journal.ppat.1007819","article-title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies","volume":"15","author":"Zhou","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2023.02.005_bib105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.immuni.2023.02.005_bib106","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.immuni.2023.02.005_bib107","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.immuni.2020.10.023","article-title":"Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity","volume":"53","author":"Liu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.02.005_bib108","doi-asserted-by":"crossref","first-page":"e2102181","DOI":"10.1002\/advs.202102181","article-title":"Neutralizing antibodies to SARS-CoV-2 selected from a human antibody library constructed decades ago","volume":"9","author":"Qiang","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.immuni.2023.02.005_bib109","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2023.02.005_bib110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"Phenix: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2023.02.005_bib111","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.immuni.2023.02.005_bib112","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2023.02.005_bib113","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2023.02.005_bib114","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bioinformatics\/btv552","article-title":"ANARCI: antigen receptor numbering and receptor classification","volume":"32","author":"Dunbar","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2023.02.005_bib115","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.05957-11","article-title":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease","volume":"86","author":"Frieman","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2023.02.005_bib116","doi-asserted-by":"crossref","first-page":"e0131451","DOI":"10.1371\/journal.pone.0131451","article-title":"New metrics for evaluating viral respiratory pathogenesis","volume":"10","author":"Menachery","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.immuni.2023.02.005_bib117","doi-asserted-by":"crossref","first-page":"14909","DOI":"10.1128\/JVI.79.23.14909-14922.2005","article-title":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice","volume":"79","author":"Yount","year":"2005","journal-title":"J.\u00a0Virol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761323000791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761323000791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:55:32Z","timestamp":1786218932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761323000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1074761323000791"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2023.02.005","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.04.479488","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}